Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)
Sector: Medical
Current Price :
$67.18
52 Week Low
$33.05
52 Week High
$67.18
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
126M
Market Cap:
$8.25B
Avg Volume:
1011080
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Biomarin Pharma (BMRN) Buys Zacharon Pharmaceuticals
Jan 07, 2013 10:19 AM |
BMRN
Strong Pre-Election Session
Nov 06, 2012 11:52 PM |
AAPL
,
AMZN
,
ARMHY
,
ARRY
,
BCO
,
BMRN
Analysts' Rating And Target Changes: BMRN, CMG, ESRX, TDC, USM, Z
Nov 06, 2012 12:19 PM |
BMRN
,
CMG
,
ESRX
,
TDC
,
USM
More Articles on BMRN..
Press Releases
BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 20, 2013 09:02 AM |
BMRN
BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO
May 16, 2013 05:50 PM |
BMRN
BioMarin to Present at the UBS Global Healthcare Conference
May 14, 2013 09:02 AM |
BMRN
More Press Releases on BMRN..
SEC Filings
Form 4 BIOMARIN PHARMACEUTICAL For: Mar 06 Filed by: GREY MICHAEL G (10K)
Mar 08, 2013 05:56 PM
Form 4 BIOMARIN PHARMACEUTICAL For: Mar 04 Filed by: Davis George Eric (10K)
Mar 06, 2013 06:54 PM
Form 4 BIOMARIN PHARMACEUTICAL For: Mar 04 Filed by: Ajer Jeffrey Robert (10K)
Mar 06, 2013 06:40 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
BMRN
Compare to S&P
YTD
33.01 %
21.97 %
4 Weeks
8.43 %
8.55 %
12 Weeks
18.12 %
14.15 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-975.00 %
EPS Growth in Last Year:
-86.96 %
Sales Growth in Last Quarter:
2.98 %
Sales Growth in Last Quarter:
22.34 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##